<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Multiomic Enriched Blood-Derived Digital Signatures Reveal Mechanistic and Confounding Disease Clusters for Differential Diagnosis - Health AI Hub</title>
    <meta name="description" content="Understanding disease relationships through blood biomarkers offers a pathway toward data driven taxonomy and precision medicine. We constructed a digital blood">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Multiomic Enriched Blood-Derived Digital Signatures Reveal Mechanistic and Confounding Disease Clusters for Differential Diagnosis</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.10888v1" target="_blank">2511.10888v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-14
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Bolin Liu, Alexander Fulton, Hector Zenil
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> q-bio.OT
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.98 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.10888v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.10888v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">Understanding disease relationships through blood biomarkers offers a pathway toward data driven taxonomy and precision medicine. We constructed a digital blood twin from 103 disease signatures comprising longitudinal hematological and biochemical analytes. Profiles were standardized into a unified ...</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>Medical/health related research</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The paper applies machine learning and computational methods (hierarchical clustering, PCA, UMAP, Random Forest feature selection) to analyze multiomic blood-derived digital signatures. This constitutes a medical AI application for: 1) improving differential diagnosis by identifying disease clusters and shared mechanistic pathways, 2) refining disease ontology, 3) mapping comorbidities, and 4) advancing precision diagnostics based on routine laboratory data.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>See abstract for details</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>See paper for methodology</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>See abstract</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>Potential clinical applications</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>Not analyzed</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>Not analyzed</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">q-bio.OT</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">q-bio.OT</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Understanding disease relationships through blood biomarkers offers a pathway toward data driven taxonomy and precision medicine. We constructed a digital blood twin from 103 disease signatures comprising longitudinal hematological and biochemical analytes. Profiles were standardized into a unified disease analyte matrix, and pairwise Pearson correlations were computed to assess similarity. Hierarchical clustering revealed robust grouping of hematopoietic disorders, while metabolic, endocrine, and respiratory diseases were more heterogeneous, reflecting weaker cohesion.
  To evaluate structure, the tree was cut at a stringent threshold, yielding 16 groups. Enrichment of the largest heterogeneous cluster (Cluster 9) showed convergence on cytokine-signaling pathways, indicating shared immunological and inflammatory mechanisms across clinical boundaries. Dimensionality reduction with PCA and UMAP corroborated these results, consistently separating hematological diseases. Random Forest feature selection identified neutrophils, mean corpuscular volume, red blood cell count, and platelets as the most discriminative analytes, reinforcing hematopoietic markers as key drivers.
  Collectively, these findings show that blood-derived digital signatures can recover clinically meaningful clusters while revealing mechanistic overlaps across categories. The coherence of hematological diseases contrasts with the dispersion of systemic and metabolic disorders, underscoring both the promise and limits of blood-based classification. This framework highlights the potential of integrating routine laboratory data with computational methods to refine disease ontology, map comorbidities, and advance precision diagnostics.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>23 pages</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>